Skip to main content

Table 5 LDL window in 528 patients with CAD including diabetes

From: Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels

 

“LDL window”

Groups

Normal

Hyper-TG

Hyper-apoB

Hyper-TG/-apoB

Number (M/F)

312 (244/68)

76 (67/9)

63 (46/17)

77 (57/20)

%N/total N

59.1

14.4

11.9

14.6

Diabetes, n (%)

102 (32.6)

23 (30.2)

20 (31.7)

29 (37.6)

Total cholesterol, mg/dl

180.7 ± 27.2

191.6 ± 22.8a

232.9 ± 29.7a,b

239.4 ± 29.7a,b

HDL-C, mg/dl

49.8 ± 14.3

43.7 ± 12.3a

46.1 ± 11.7

40.7 ± 8.8a

TG, mg/dl

92.1 ± 28.1

222.6 ± 86.1a

104.6 ± 32.1b

223.1 ± 70.3a,c

LDL-C, mg/dl

106.5 ± 22.9

105.9 ± 20.0

159.5 ± 25.7a,b

153.3 ± 28.3a,b

sdLDL-C, mg/dl

26.6 ± 13.9

37.6 ± 14.6a

44.1 ± 24.6a

60.8 ± 19.0a,b,c

lbLDL-C, mg/dl

79.9 ± 23.0

68.3 ± 23.9a

115.3 ± 33.5a,b

92.4 ± 31.5a,b,c

Non-HDL-C, mg/dl

130.9 ± 22.2

147.9 ± 20.8a

186.8 ± 25.9a,b

198.6 ± 26.5a,b,c

sdLDL-C/LDL-C, %

25.4 ± 13.3

36.5 ± 15.0a

28.0 ± 15.2b

40.8 ± 13.4a,c

ApoB, mg/dl

85.0 ± 14.3

94.5 ± 11.6a

124.4 ± 13.6a,b

132.2 ± 16.5a,b,c

LDL-C/apoB

1.25 ± 0.16

1.11 ± 0.15a

1.28 ± 0.14b

1.15 ± 0.13a,c

LDL size, nm

25.7 ± 0.36

25.3 ± 0.43a

25.7 ± 0.32b

25.4 ± 0.40a,c

Pattern B, n (%)*

111 (35.6)

59 (77.6)

25 (39.7)

62 (80.5)

sdLDL-C Q1, Q2, Q3, Q4, n

61, 75, 81, 95

3, 5, 23, 45

3, 5, 13, 42

0, 0, 3, 74

sdLDL-C Q1, Q2, Q3, Q4, %

19.6, 24.0, 26.0, 30.5

4.0, 6.6, 30.3, 59.2

4.8, 7.9, 20.6, 66.7

0, 0, 3.9, 96.1

  1. Data are expressed as mean ± standard deviation
  2. HDL-C high-density lipoprotein-cholesterol, TG triglycerides, LDL-C low-density lipoprotein-cholesterol, sdLDL-C small dense LDL-C, lbLDL-C large buoyant LDL-C, Non-HDL-C non high-density lipoprotein-cholesterol, Apo apolipoprotein, Pattern B LDL phenotype with an average diameter of <25.5 nm
  3. Significance at p < 0.0001–0.05 by ANOVA
  4. *Statistically significant differences
  5. avs. normal; bhyper-TG; cvs.hyper-apoB